Physician

Robert T Sparrow, MD

According to 2025 Medicare claims, Robert Sparrow, MD (NPI: 1134259781) practices nephrology in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is RENALCARE ASSOCIATES, S.C. (NPI: 1649300377; TIN: 370995483) and primary practice location at 61603-3168. Sparrow is affiliated with the IRCCO (ACO ID: A2619) and OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Sparrow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 386 traditional Medicare patients, billed 5,958 HCPCS/CPT codes, and received $221,603 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,913 prescription claims across 450 beneficiaries totaling $60,154 in drug costs, led by Potassium Chloride (Potassium Chloride). DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $262,696 to $221,603. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $242,793 to $60,154. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,229	17,647	$262,696
2016	530	4,592	$59,716
2017	185	545	$41,102
2018	244	825	$61,045
2019	296	1,323	$82,625
2020	347	1,088	$85,656
2021	366	1,074	$96,969
2022	354	928	$81,130
2023	334	769	$67,544
2024	386	5,958	$221,603

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	592	6,738	$242,793
2016	514	5,562	$197,765
2017	334	2,838	$117,444
2018	259	2,325	$63,843
2019	286	2,452	$87,078
2020	359	2,970	$94,312
2021	395	3,038	$79,434
2022	408	3,014	$64,880
2023	428	2,841	$80,819
2024	450	2,913	$60,154

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	46	605	$36,430
2016	24	411	$19,814
2017	N/R	250	$18,087
2018	N/R	178	$10,579
2019	N/R	174	$6,794
2020	N/R	120	$3,504
2021	N/R	132	$2,422
2022	N/R	146	$2,877
2023	N/R	102	$2,268
2024	N/R	11	$169

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	240	380	$76
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	173	1,207	$36
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	159	2,584	$30
99453	Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment	149	152	$14
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	208	279	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Potassium Chloride	Potassium Chloride	60	4,126	$4,245
Labetalol Hcl	Labetalol Hcl	131	8,532	$3,840
Chlorthalidone	Chlorthalidone	281	19,308	$3,543
Eplerenone	Eplerenone	17	810	$2,700
Hydralazine Hcl	Hydralazine Hcl	185	11,089	$2,597

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$169

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Robert T. Sparrow, MD?

Tedicare shows public-source Medicare data for Robert T. Sparrow, MD (NPI 1134259781), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert T. Sparrow, MD have ACO affiliation data?

Robert T. Sparrow, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Robert T. Sparrow, MD?

Robert T. Sparrow, MD is linked to RENALCARE ASSOCIATES, S.C. (billing NPI 1649300377) in the available physician profile data.

Does Robert T. Sparrow, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.